跳转至内容
Merck
所有图片(1)

文件

P3296

Millipore

蛋白G琼脂糖凝胶™，快速流动

recombinant, expressed in E. coli, aqueous ethanol suspension

别名:

蛋白G琼脂糖，快速流动 来源于链球菌 属

登录查看公司和协议定价
所有图片(1)

About This Item

MDL號碼:
MFCD00165580
分類程式碼代碼:
41106500
NACRES:
NA.56

重組細胞

expressed in E. coli

形狀

aqueous ethanol suspension

分析物化學類別

proteins (Immunoglobulins of various mammalian species)

標籤範圍

~2 mg per mL

技術

affinity chromatography: suitable

基質

Sepharose 4B Fast Flow

基質活化

cyanogen bromide

基質結合

amino

基質墊片

1 atom

儲存溫度

2-8°C

正在寻找类似产品? 访问 产品对比指南

相关类别

一般說明

蛋白G是从G组链球菌菌株G-148中分离得到的细菌胞壁蛋白，它能与免疫球蛋白（IgG）结合。通过木瓜蛋白酶消化从细胞中提取该蛋白，并依次使用DEAE-Sephadex离子交换层析、琼脂糖凝胶偶联人IgG亲和层析以及Sephadex G-200凝胶层析进行纯化。蛋白G与各种多克隆和单克隆IgG结合的pH条件基本在2.8-10之间，在pH 4-5时结合最强，在pH 10时结合最弱。它是强大的IgG检测试剂。
蛋白G是从G组链球菌菌株G-148中分离得到的细菌胞壁蛋白，它能与免疫球蛋白（IgG）结合。通过木瓜蛋白酶消化从细胞中提取该蛋白，并依次使用DEAE-Sephadex离子交换层析、琼脂糖凝胶偶联人IgG亲和层析以及Sephadex G-200凝胶层析进行纯化。蛋白G与各种多克隆和单克隆IgG结合的pH条件基本在2.8-10之间，在pH 4-5时结合最强，在pH 10时结合最弱。它是强大的IgG检测试剂。

P3296-5Ml的最新产品编号为GE17-0618-01

應用

蛋白G琼脂糖凝胶™ 被用于亲和层析，蛋白质层析，抗体纯化和表征，免疫亲和基质，蛋白A、G和L树脂，蛋白质相互作用以及纯化和检测。蛋白G琼脂糖凝胶™ 已被用于开发一种可确认人血清中是否存在抗促红细胞生成素中和抗体的方法，以及比较马血清中白蛋白和IgG消耗的方法。

外觀

悬浮于20%乙醇中

準備報告

使用重组链球菌蛋白G制备，其中白蛋白结合区已被移除

法律資訊

Sepharose is a trademark of Cytiva

象形圖

Flame
GHS02

訊號詞

Warning

危險聲明

H226

危險分類

Flam. Liq. 3

儲存類別代碼

3 - Flammable liquids

水污染物質分類（WGK）

WGK 3

閃點（°F）

115.0 °F - closed cup

閃點（°C）

46.1 °C - closed cup

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ （Lot或Batch）字后找到。

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

G Yang et al.
Oncogene, 26(1), 91-101 (2006-06-27)
The t(8;21) chromosomal translocation that generates the fusion oncoprotein RUNX1-ETO predominates in leukemia patients of the French-American-British (FAB) class M2 subtype. The oncoprotein has the capacity to promote expansion of hematopoietic stem/progenitor cells and induces leukemia in association with other
Cristina Hidalgo-Carcedo et al.
Nature cell biology, 13(1), 49-58 (2010-12-21)
Collective cell migration occurs in a range of contexts: cancer cells frequently invade in cohorts while retaining cell-cell junctions. Here we show that collective invasion by cancer cells depends on decreasing actomyosin contractility at sites of cell-cell contact. When actomyosin
B Akerström et al.
The Journal of biological chemistry, 261(22), 10240-10247 (1986-08-05)
Protein G, an IgG-binding molecule, was prepared from the cell walls of a group G streptococcal strain, G-148. The protein could be extracted from the cells by papain digestion and purified by the sequential use of ion-exchange chromatography on DEAE-Sephadex
B Akerström et al.
Journal of immunology (Baltimore, Md. : 1950), 135(4), 2589-2592 (1985-10-01)
Protein G is an immunoglobulin (IgG)-binding bacterial cell wall protein recently isolated from group G streptococci. We have investigated the avidity of protein G for various monoclonal and polyclonal Ig of the IgG class, and compared it with the binding
Yi-Jye Chern et al.
Cell death & disease, 10(7), 504-504 (2019-06-28)
Therapy-refractory disease is one of the main contributors of treatment failure in cancer. In colorectal cancer (CRC), SPARC can function as a sensitizer to conventional chemotherapy by enhancing apoptosis by interfering with the activity of Bcl-2. Here, we examine a
查看所有相关文献

实验方案

Immunoprecipitation Procedure

Techniques for protein antigen molecular weight determination, protein interactions, enzymatic activity, and post-translational modifications.

Immunoprecipitation Procedure

Techniques for protein antigen molecular weight determination, protein interactions, enzymatic activity, and post-translational modifications.

Immunoprecipitation Procedure

Techniques for protein antigen molecular weight determination, protein interactions, enzymatic activity, and post-translational modifications.

Immunoprecipitation Procedure

Techniques for protein antigen molecular weight determination, protein interactions, enzymatic activity, and post-translational modifications.

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门